Stem Loop Mediated Transgene Modulation in Human T Cells
Controlling gene expression is useful for many applications, but current methods often require external user inputs, such as the addition of a drug. We present an alternative approach using cell-autonomous triggers based on RNA stem loop structures in the 3' untranslated regions (UTRs) of mRNA. These stem loops are targeted by the RNA binding proteins Regnase-1 and Roquin-1, allowing us to program stimulation-induced transgene regulation in primary human T cells. By incorporating engineered stem loops into the 3' UTRs of transgenes, we achieved transgene repression through Regnase-1 and Roquin-1 activity, dynamic upregulation upon stimulation, and orthogonal tunability. To demonstrate the utility of this system, we employed it to modulate payloads in CAR-T cells. Our findings highlight the potential of leveraging endogenous regulatory machinery in T cells for transgene regulation and suggest RNA structure as a valuable layer for regulatory modulation.
Authors
- Neil C. Sheppard (ORCID: https://orcid.org/0000-0002-9551-9491)
- Carl H. June (ORCID: https://orcid.org/0000-0003-0241-3557)
- Philipp C. Rommel (ORCID: https://orcid.org/0000-0002-9790-4086)
- David Mai (ORCID: https://orcid.org/0000-0002-9238-0164)
- Carly M. Harro (ORCID: https://orcid.org/0000-0002-0683-217X)
- A. Sanyal
Institutions
- Parker Institute for Cancer Immunotherapy (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- ACS Synthetic Biology
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1021/acssynbio.4c00152
- Citations
- 1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Robert Wood Johnson Foundation
- University of Pennsylvania
- Parker Institute for Cancer Immunotherapy
- Emerson Collective
- National Institutes of Health
- Perelman School of Medicine, University of Pennsylvania